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Abstract
Background: Myelination requires precise control of oligodendrocyte morphology and myelin
generation at each of the axons contacted by an individual cell. This control must involve the
integration of extracellular cues, such as those on the axon surface, with intrinsic developmental
programmes. We asked whether integrins represent one class of oligodendrocyte cell-surface
receptors able to provide this integration.
Results: Integrins signal via a process of activation, a conformational change that can be induced
either by "outside-in" signals comprising physiological extracellular matrix ligands (mimicked by the
pharmacological use of the divalent cation manganese) or "inside-out" signalling molecules such as
R-Ras. Increasing levels of outside-in signalling via the laminin receptor α6β1 integrin were found
to promote oligodendrocyte processing and myelin sheet formation in culture. Similar results were
obtained when inside-out signalling was increased by the expression of a constitutively-active R-
Ras. Inhibiting inside-out signalling by using dominant-negative R-Ras reduces processes and myelin
sheets; importantly, this can be partially rescued by the co-stimulation of outside-in signalling using
manganese.
Conclusion: The balance of the equilibrium between active and inactive integrins regulates
oligodendrocyte morphology, which is itself regulated by extrinsic and intrinsic cues so providing
a mechanism of signal integration. As laminins capable of providing outside-in signals are present on
axons at the time of myelination, a mechanism exists by which morphology and myelin generation
might be regulated independently in each oligodendrocyte process.
Background
The process of myelination in the CNS requires a remark-
able morphological transformation by newly-formed oli-
godendrocytes, with processes contacting and extending
along each axon before elaborating a myelin membrane
to enwrap the axon multiple times to create a sheath. This
differentiation step is tightly controlled, as indicated by
the formation of processes each with sufficient membrane
for a sheath thickness that has a precise relationship with
final axon diameter [1]. In order to ensure that the precise
amount of myelin is formed at the right developmental
stage and in the correct place, a key component of oli-
godendrocyte behaviour during myelin formation must
be the integration of multiple extrinsic signals at the axon
surface along with intrinsic programmes, such as autono-
mous developmental timers of differentiation. These
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understanding of myelination and may facilitate the
development of strategies to promote remyelination.
One important group of candidate integrative molecules
are the integrins, the cell surface receptors of extracellular
matrix proteins. Integrins comprise two transmembrane
chains, termed α and β, with a ligand-binding site formed
by the head domain of the two chains [2]. Recent work
has established that integrins exist in at least three differ-
ent confirmations on the cell surface, each in a dynamic
equilibrium with one another (Fig 1A) [3-7]. Inactive
integrins are folded over, have a low binding affinity for
ligand and do not signal. Primed integrins are straight-
ened, and bind ligand with higher affinity as a result of
shape changes within the head domain. Activated
integrins have bound ligand leading to receptor cluster-
ing, and have undergone a further shape change in the β
chain leading to separation of the two cytoplasmic
domains, thereby allowing formation of the signalling
complex (termed "outside-in" signalling). Since the
change of shape can be transmitted across the membrane
in either direction, activation can also be achieved by so
called "inside-out" signals. These separate cytoplasmic
domains and induce changes in the extracellular ligand-
binding site that increase receptor affinity, leading to lig-
and binding, integrin clustering and signalling. As a result,
integrin activation and formation of the signalling com-
plex is regulated by the integration of both extrinsic ligand
concentrations and the activity of (intrinsic) 'inside out'
signalling pathways.
Oligodendrocytes express 5 integrins; αVβ1, αVβ3, αVβ5
and αVβ8 as well as α6β1 [8,9]. In cell culture, the αV
integrins promote proliferation and migration [10,11],
while the laminin receptor, α6β1, promotes differentia-
tion (as measured by myelin sheet formation) and sur-
vival [12,13]. In vivo, mice lacking α6 show increased
apoptosis of newly-formed oligodendrocytes [14]. Trans-
plantation of cells expressing dominant-negative β1
integrins into focal demyelinated lesions in the adult rat
reduced the extent of remyelination [15]. We therefore
focused on α6β1 to examine the hypothesis that integrin
activation provides a mechanism for the integration of
extrinsic and intrinsic signals in oligodendrocyte differen-
tiation. Our goal was to test two key predictions of the
hypothesis (Fig 1B and 1C): (i) that either extracellular or
intracellular signals regulating integrin activation can con-
trol oligodendrocyte morphology, and (ii), that the effects
of inhibition of one class of signals could be partially
overcome by stimulation of the other, so demonstrating
integration of signals by the integrin.
Results
We have shown previously that laminin-2 substrates pro-
mote the formation of a differentiated morphological
phenotype in oligodendrocytes, as evidenced by increased
elaboration of processes and myelin sheets, and that α6
and β1 integrin subunits are found throughout the proc-
Strategies for manipulating integrin activation in oligodendro-cytesFigure 1
Strategies for manipulating integrin activation in oligodendro-
cytes. Panel A shows the equilibrium between 3 different 
conformations of integrin; inactive, primed and activated. 
Only the latter assembles a signalling complex and promotes 
morphological differentiation of oligodendrocytes, as mani-
fested by complex processes and the formation of myelin 
sheets. Panel B shows the 2 methods used in this study to 
promote activation; outside-in signalling using high extracellu-
lar matrix (ECM) ligand concentrations or the divalent cation 
Mn2+ (results in Fig 2), and inside-out signalling using active R-
Ras (Fig 3). Panel C illustrates the logic of the experiment 
shown in Fig 4 to confirm that integrins integrate these 
extracellular and intracellular cues, showing how outside-in 
signalling would be predicted to overcome the effects of R-
Ras inhibition on oligodendrocyte morphology and myelin 
sheet formation.Page 2 of 8
(page number not for citation purposes)
BMC Biology 2005, 3:25 http://www.biomedcentral.com/1741-7007/3/25ess network of oligodendrocytes [12]. To confirm that the
change in phenotype was α6β1 integrin dependent (and
can therefore be used as an assay of integration of inside-
out and outside-in signalling), oligodendrocyte morphol-
ogy was analyzed in the presence of the monoclonal anti-
body Ha2/5 (that blocks β1 integrins) and RGD peptides
(that mimic the peptide recognition sequence within the
extracellular matrix molecules recognised by αV integrins
Outside-in integrin signalling in oligodendrocytesFigure 2
Outside-in integrin signalling in oligodendrocytes. Panel A shows that morphological differentiation of oligodendrocytes on 
laminin-2 requires integrins. A monoclonal anti-β1 integrin-blocking antibody (Ha2/5) inhibits oligodendrocyte process forma-
tion on laminin-2 (Ln) but not fibronectin (Fn). In contrast, RGD peptides that block αV integrins inhibit the morphological dif-
ferentiation on Fn. No change is seen with control RAD peptides that do not perturb integrin function. Panel B shows that 
integrin activation by outside-in signalling promotes differentiation. Increasing laminin-2 concentrations are associated with 
greater process complexity and myelin sheet formation, with significant increases seen between 1 and 10 µg/ml. Mn2+ (Mn) also 
promotes differentiation, with significant effects seen at the lowest laminin-2 concentration (0.1 µg/ml). Note that the addition 
of Mn2+ has no significant effect on morphology at the higher laminin concentrations. Single and double asterix indicate signifi-
cance levels of p < 0.05 and p < 0.01 respectively, calculated using Student's paired t-test. Scale bar in panel A is 20 µm.
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While confirming previous results with polyclonal anti-β1
antibody, we also found that the monoclonal Ha2/5 anti-
body blocked morphological differentiation on laminin-
2 (Fig 2A). In contrast, this antibody had little effect on
fibronectin substrates, which promote process outgrowth
but not myelin sheet formation and on which the RGD
peptide was an effective inhibitor (Fig 2A). Since αVβ1
and α6β1 are the only β1 integrins expressed on oli-
godendrocytes, and because RGD peptides would be
expected to block αVβ1, we conclude that morphological
differentiation leading to myelin sheet formation by oli-
godendrocytes on laminin-2 is α6β1-dependent.
To confirm that extracellular signals regulate oligodendro-
cyte morphology by activation of α6β1, oligodendrocyte
precursor cells were plated on increasing concentrations
of laminin-2 and allowed to differentiate into oli-
godendrocytes. Oligodendrocyte morphology was scored
as having either simple (primary) processes only, complex
(secondary and tertiary) processes or myelin sheets,
reflecting the different changes associated with axon con-
tact and sheath formation. Increasing the laminin-2 coat-
ing concentration from 1 to 10 µg/ml resulted in a
significantly greater degree of morphological differentia-
tion (Fig 2B). To exclude the possibility that this repre-
sented signalling by a second non-integrin receptor rather
Inside-out integrin signalling in oligodendrocytesFigure 3
Inside-out integrin signalling in oligodendrocytes. Panel A shows an RT-PCR experiment on cDNA obtained from cultured oli-
godendrocytes, grown as described in the Methods. Lane 1 – size markers (nt); lane 2 – ADAM9 (control); lane 3 – R-Ras. 
Panel B shows a western blot of lysates from 3 different sets of cultured oligodendrocytes (lanes 1–3) using anti-R-Ras antibod-
ies. All 3 lanes show a band at the predicted size (23 kD) of R-Ras (arrow). Size markers (kDa) shown on the left. These 2 
experiments therefore confirm that oligodendrocytes express R-Ras. Panel C shows the effect of expressing constitutively 
active R-Ras (R-Ras38V) in oligodendrocytes, while Panel D shows the effect of expressing the dominant-negative R-Ras43N; 
all 4 micrographs in each panel show representative examples of transfected cells visualised by antibodies against EGFP (green) 
and CNPase (red). Note the different morphologies observed, with elaborate processes and large sheets seen in some cells 
expressing R-Ras38V and stunted processes in some expressing R-Ras43N. The effects of R-Ras38V and R-Ras43N at different 
laminin-2 concentrations are quantified in Panels F and G, with control cells (expressing wild-type R-Ras) in these experiments 
shown in panel E. These show the increased complexity of R-Ras38V cells at all laminin-2 concentrations when compared with 
wild-type cells, in contrast to the decreased complexity of the R-Ras43N cells. Single and double asterix indicate significance 
levels of p < 0.05 and p < 0.01 respectively, calculated using Student's paired t-test. Scale bars in panels C and D are 20 µm.Page 4 of 8
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Mn2+ to the tissue culture media. This divalent cation
replaces the Ca2+ normally present in the integrin ligand-
binding domain and activates the integrin as a result of
the conformational changes associated with the substitu-
tion. At low coating concentrations of laminin-2 (0.1 µg/
ml), Mn2+ significantly increased morphological differen-
tiation, but had no effect at higher concentrations (Fig
2B). This result would be expected if either high ECM con-
centrations (1 µg/ml and above) or Mn2+ were sufficient
to activate the oligodendrocyte α6β1 integrins effectively,
while lower ECM concentrations only elicited partial acti-
vation. Consequently, Mn2+ promotes further differentia-
tion at low ECM concentrations (by activating those
integrins not already activated by the ECM) but has no sig-
nificant additive effect at the high ECM concentrations.
The effect of intracellular signalling pathways that regulate
integrin activation was explored. Both RT-PCR and west-
ern blotting studies confirmed the presence of R-Ras in
oligodendroglial cells (Fig 3A,B), shown to regulate
integrin activation in other cell types [17,18]. To manipu-
late R-Ras signalling, transient transfections of primary
oligodendrocyte precursor cell populations were used to
express either wild-type (control) or mutant forms of R-
Ras [19]. Expression of a constitutively active mutant form
of R-Ras (38V) resulted in a dramatic increase in sheet for-
mation by the oligodendrocytes (Fig 3C). Quantification
revealed that this increase was significantly greater than
that seen in cells expressing wild-type R-Ras at the highest
laminin-2 concentrations tested, with >80% of the cells
expressing sheets at 10 µg/ml (Fig 3F).
Conversely, a dominant negative R-Ras construct (43N)
reduced the degree of morphological differentiation seen
in response to laminin-2 (Fig 3D). When compared with
cells expressing wild-type R-Ras, the percentage of oli-
godendrocytes with a complex morphology was signifi-
cantly reduced at laminin-2 concentrations above 0.1 µg/
ml, with the percentage exhibiting a simple morphology
correspondingly increased (Fig 3G). Together with the
data using the constitutively-active R-Ras38V, these results
point to the presence on the surface of the oligodendro-
cyte of a dynamic equilibrium between inactive and acti-
vated α6β1 that can be displaced in either direction by
manipulation of R-Ras signalling. Moreover, when con-
sidered with the experiments using high laminin-2 coat-
ing concentrations and/or Mn2+, they confirm our first
prediction that either intracellular or extracellular cues
regulating activation can control oligodendrocyte mor-
phology.
To test the second prediction of the hypothesis that this
equilibrium provides a mechanism for integrating intrac-
ellular and extracellular cues, we determined whether the
effects of inhibiting activation by dominant negative R-
Ras (an "inside-out" signal) could be overcome by stimu-
lating activation using Mn2+ (an "outside-in" signal), as
illustrated in Fig 1C. Mn2+ increased the extent of sheet
formation, and decreased the percentage of cells with a
simple morphology, in cells expressing the dominant neg-
ative R-Ras construct at the two lower laminin concentra-
tions tested (Fig 4). Because Mn2+ acts directly on the
integrin ligand binding domain, we can conclude that the
increase in sheet formation reflects a direct effect on the
integrin and therefore on the equilibrium between inac-
tive and active integrins, rather than via modulation of
separate downstream signalling pathways.
Discussion
These results show that the equilibrium between active
and inactive integrins regulates oligodendrocyte mor-
phology and myelin sheet formation. The balance of this
equilibrium is determined by a combination of intracellu-
lar signals and extracellular ligand concentrations, with
the two classes of signal integrated by individual integrin
heterodimers. Manipulation of the equilibrium provides
one mechanism by which both the number of myelin
sheaths formed by an individual oligodendrocyte, as well
as their thickness, could be regulated during CNS develop-
ment.
To be relevant to myelination in vivo, our results require
the presence of signals in the developing brain that can
promote both outside-in and inside-out integrin signal-
Outside-in integrin signalling rescues the effect of dominant-negativ  R-Ras43NFi ure 4
Outside-in integrin signalling rescues the effect of dominant-
negative R-Ras43N. In the same set of experiments illus-
trated in Fig 3, Panel G, addition of Mn2+ significantly 
increases oligodendrocyte complexity in the cells expressing 
dominant-negative R-Ras. *p < 0.05.
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chain present in the laminin trimers 2,4 and 12) is present
on the surface of axons in embryonic brainstem at the
time of myelination [14], extending a previous report of
laminin α2 expression by Purkinje cells in the myelinat-
ing postnatal cerebellum [20]. Binding of this laminin
would provide an outside-in signal, as shown in the exper-
iments using increasing laminin concentrations. A
number of different extracellular signals might trigger the
intracellular pathways that promote inside-out signalling.
For example, our previous work has defined a role for
growth factors and their receptors in integrin activation
via "inside-out" signalling. In studies on cell proliferation
of oligodendrocyte precursors, αvβ3 integrin was acti-
vated by PDGF [21]. Activation of αvβ3 had been previ-
ously described in response to VEGF in endothelial cells
[22], suggesting this might represent a general mechanism
for integrin/growth factor interactions. Two other extra-
cellular signalling systems, eph/ephrins and semaphorins,
have also been shown to alter integrin activation [23-25].
Equally, the key intracellular components of the inside-
out signalling pathway are present in oligodendrocytes.
We have reported here that R-Ras is expressed in oligoden-
droglia. Recent work has shown that the interaction of the
cytoskeletal protein talin with the β integrin cytoplasmic
domain represents a final common pathway for the sig-
nals that promote activation [26], and we have also found
that talin is expressed in oligodendroglial cells (Uli Forster
and C ff-C, unpublished observations) consistent with
such a role in these cells.
These observations show that there are multiple potential
signalling pathways that might regulate the equilibrium
of active and inactive integrins. Together with our present
results, they support a model by which this equilibrium
provides a dynamic means of integrating multiple signals
to control the timing of myelination and the extent of
myelin membrane. The model is based on the assumption
that, under physiological conditions during normal devel-
opment where growth factors are present in limiting con-
centrations, two classes of signals are required to generate
sufficient numbers of activated integrins. So, for example,
the laminin on the axon surface would be necessary for
integrin signalling and myelination, but may not be suffi-
cient without a further contribution to integrin activation
from intracellular ("inside-out") signals. These "inside-
out" signals could be generated by growth factor signal-
ling, or alternatively from intracellular pathways driven by
autonomous developmental clocks [27], and would then
effectively act as timers of myelination. Equally, while
these intracellular signals may initiate the myelination
process, the amount of myelin formed (and hence the
number of wraps) would then be determined by the con-
centration of extracellular ligand on the axon surface, with
higher concentrations increasing integrin activation and
so the amount of myelin produced. A precedent for wrap-
number being determined by the concentration of axon-
surface molecules is provided by the PNS, where trans-
membrane isoforms of neuregulin regulate Schwann cell
myelination [28,29]. There is no evidence that laminins
provide quantitative signals to the myelinating oli-
godendrocytes, but the observation that laminin-2 defi-
cient dy/dy mutant mice show an increased G ratio
(reflecting thinner myelin) in the CNS [30] would be con-
sistent with such signals, and further studies are required.
Conclusion
Oligodendrocyte morphology is regulated at least in part
by the balance of active and inactive integrins (Fig 1A).
Such a model provides important insights into two
aspects of oligodendrocyte biology. First, a single oli-
godendrocyte can myelinate multiple axons, and the
thickness of each sheath (and therefore the amount of
myelin membrane produced at the end of each process) is
independently regulated by the axon it ensheaths. Clearly,
this remarkable example of local control of cell-cell inter-
actions cannot be regulated entirely by changes in tran-
scription or translation initiated in the cell body.
However, the control of integrin signalling by alterations
of the equilibrium between active and inactive integrins
provides a plausible mechanism by which integrin ligands
on the axon could regulate membrane formation and
morphological changes independently within each proc-
ess. Second, one hypothesis for the failure of remyelina-
tion in MS (the dysregulation hypothesis) is that the loss
of the coordination between promyelinogenic signals,
rather than the loss of any one specific factor, prevents
repair [31]. The possibility that integrative signalling mol-
ecules such as integrins might provide targets for drug
therapies designed to promote remyelination by activa-
tion and promotion of signalling in the absence of the
usual upstream cues therefore requires further investiga-
tion.
Methods
Oligodendrocyte cultures
Purified oligodendrocyte precursor cells were obtained
from primary cultures of newborn Sprague-Dawley rat
forebrains and were isolated by mechanical dissociation
and differential adhesion as described previously [8]. The
precursor cells were then plated on 8-well Permanox
chamber slides (Nunc) pre-coated with fibronectin (10
µg/mL; Sigma) or laminin-2 (0.01, 0.1, 1 and 10 µg/mL;
Sigma human placental laminin) at 20,000 cells/well. For
both the blocking experiments and the Mn2+ experiments,
the cells were allowed to attach to the substrate for 2 h at
37°C before adding either blocking reagents or Mn2+.
Ha2/5 antibody (PharMingen) was used at 10 µg/mL,
blocking peptides (RGD and RAD; Calbiochem) were
used at 0.1 µg/mL and Mn2+ (MnCl2·4H2O; Sigma) wasPage 6 of 8
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ferentiation in SATO medium [8] at 37°C, 7.5% CO2,
cells were fixed with 4% paraformaldehyde for 15 min at
room temperature. The cells were permeabilised and
blocked in a one-step procedure with 10% normal goat
serum (NGS, Sigma) and 0.1% TritonX-100 (NBS Biolog-
icals) in PBS for one hour at room temperature prior to
immunostaining.
Transfection
After 10–12 days in vitro, the forebrain cultures were
rinsed twice with DMEM (Sigma) supplemented with
10% fetal bovine serum (Sigma) and subsequently trans-
fected overnight with the following constructs; pEGFP-
C1/R-Ras-wt, pEGFP-C1/R-Ras-38V and pEGFP-C1/R-
Ras-43N using FuGene 6.0 (Roche). The R-Ras constructs
have been previously described [19], and were a kind gift
of Prof Alan Hall (UCL, London, UK). They were recloned
into the pEGFP-C1 vector (Clontech) following digestion
with BamHI and XbaI. The cells were then washed three
times with DMEM (10% fetal bovine serum) and 24 h
later they were plated onto laminin-2 substrates as
described above at 40,000 cells/well. The cells were differ-
entiated for 3 days before fixation, permeabilisation and
blocking in preparation for the immunostaining.
Immunostaining
Cells were washed three times with PBS and were incu-
bated with appropriate dilutions of the primary antibod-
ies in a buffer of PBS, 1% NGS and 0.1% Triton X-100 for
1–2 h at room temperature or overnight at 4°C. Myelin
basic protein (MBP) staining was carried out using a 1:50
dilution of rat anti-MBP (82–87) (Serotec). A 1:100 dilu-
tion of mouse anti-2',3'-cyclic nucleotide 3'-phosphohy-
drolase (CNPase clone 11-5B, Sigma) was used for
CNPase staining. For enhanced green fluorescence protein
(EGFP) staining rabbit anti-GFP IgG (1 µg/mL corre-
sponding to 1:1000, Molecular Probes) was used. After
washing with PBS, the cells were incubated with second-
ary antibodies (Jackson ImmunoResearch Laboratories
INC.) diluted 1:100 in PBS with 1% NGS for 1 h at room
temperature.
RT-PCR and Western blotting
Total RNA was isolated from oligodendrocyte precursor
cells and cDNA was made using a first strand cDNA syn-
thesis kit (Amersham) according to the manufacturer's
instructions. For the RT-PCR the primer sequences were:
ADAM9 (control) GCCTGACGAAGCCTACA and GTC-
CACGCTTCCTCCTAT; R-Ras GGTTGGGAACAAGGCA-
GATC and GCAGGACACAGGGACATCC. For western
blotting, differentiated oligodendrocytes were lysed and
scraped off in 250 µL lysis buffer (50 mM Tris-HCl, 5 mM
EDTA, 150 mM NaCl, 1% Triton X-100, pH7.4), with the
protease inhibitors phenylmethylsulfonyl fluoride (2
mM), pepstatin (1 µg/mL), leupeptin (5 µg/mL) and
aprotinin (2 µg/mL)) per 10 cm tissue culture dish. The
cell lysates were incubated for 30 min and centrifuged
(13,000 rpm) for 10 min at room temperature. Protein
concentrations were determined using a detergent com-
patible Lowry protein assay (BioRad DcProtein assay).
Denatured, boiled proteins were separated by SDS-PAGE
(12% pre-cast Tris-HCl minigels; BioRad) and transferred
onto a 0.45 µm nitrocellulose membrane (HybondC,
Amersham). The membrane was blocked in 4% bovine
serum albumin (Sigma) in TBST (TBS with 0.1% Tween
20) for 1 h at room temperature, and further incubated
with rabbit anti-R-Ras (BD PharMingen; 1:1000) in block-
ing buffer overnight at 4°C. After washing with TBST, the
membrane was incubated with a horseradish peroxidase-
conjucated secondary antibody (Amersham) in 2% block-
ing buffer for 1 h at room temperature. The membrane
was washed and the immunoreactive proteins were
detected using enhanced chemiluminescence (Amer-
sham).
Scoring
MBP+/EGFP+ cells were assigned to one of three morpho-
logical categories. Cells that had only primary processes
were assigned to the first category, which was denoted
'simple processes'. Cells with secondary and tertiary proc-
esses were assigned to a second category denoted 'com-
plex processes'. Cells with myelin sheets (as evidenced by
continuous staining filling in between the processes) were
assigned to a third category denoted 'myelin sheets'. In
each assay, 50 MBP+/EGFP+ oligodendrocytes were
scored, with the results being the M ± SEM of 3 independ-
ent experiments.
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